Skip Navigation

A Phase 2 Study of Onvansertib in Combination with Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Brief Summary

Type:
Pancreatic

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04752696

Study #:
STUDY00147222

Start Date:
Aug 25, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04752696

View Complete Trial Details & Eligibility at ClinicalTrials.gov